We harness AI to accelerate drug discovery
We use artificial intelligence (AI) technology to explain the physical and chemical nature of biological systems.
What is our philosophy?
Drug Discovery Pipeline
AI Approach and Solutions
Learn More
Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0682 in ER-Positive Breast Cancer
Sep 20, 2021
Read More
Accutar Biotech Announces Dr. Carlos Garcia-Echeverria, as CEO Advisor
Jul 08, 2021
Read More
Accutar Biotech announces world leading oncologist Dr. Pasi A. Jänne joins scientific advisory board
May 07, 2021
Read More